About Strados

The Intelligence Advantage

How Strados brings technology, scientific rigor, and human expertise together to produce regulatory-grade respiratory evidence in the real world.


Continuous by design.

Episodic clinic visits miss the disease burden that lives between appointments. Strados captures what matters — continuously in patients' daily lives — for every endpoint in the suite.


Retained. Reviewable. Auditable.

AI detects. Experts review. Audio is retained. The full evidence chain — from capture to annotation to audit — is preserved and accessible. This is what separates Strados from algorithm and human review-only solutions.


Intelligence is the standard, not a feature.

Every data point we deliver is traceable, defensible, and built for regulatory submission. Not just processed and reported — but reviewed, annotated, and audit-ready from the moment it is captured.

What Sets Us Apart

Built for Regulatory Rigor

Four principles that define how Strados generates defensible respiratory endpoints for clinical trials.

01

AI Detection + Expert Review

Across every endpoint in the suite, AI detects and classifies respiratory events while credentialed respiratory specialists review and annotate. This dual-layer evidence standard satisfies regulatory scrutiny for cough, spirometry, FeNO, and eCOA.

02

Traceable Data Sources

Unlike algorithm-only solutions that process and discard source data, Strados preserves the evidence chain. Recorded audio for cough events, spirometry maneuver videos, and all measurement parameters remain accessible for audit and regulatory submission.

03

Regulatory-Grade Evidence

FDA 510(k) cleared devices, CE marked solutions, and validated algorithms across the entire endpoint suite. Built from the ground up to meet the evidentiary standards required by pharma sponsors and regulators in decentralized clinical trials.

04

Continuous Real-World Monitoring

Clinic visits are snapshots. Strados provides the full picture — continuous, real-world measurement of respiratory burden across all endpoints, 24 hours a day, wherever the patient is.

Ready to design your respiratory study?

Tell us about your program and we'll help you design the right respiratory endpoint strategy.

Design a Study